Travere Therapeutics, Inc. (TVTX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $5.78B, a trailing price-to-earnings ratio of 67.4 and a free-cash-flow yield of -0.4%. Over the most recent reported fiscal year, revenue grew 110.5%.